154 related articles for article (PubMed ID: 1795560)
1. Squamous cell carcinoma related antigen in uterine cervical carcinoma.
Cheah PL; Yap SF; Looi LM; Sivanesaratnam V
Malays J Pathol; 1991 Jun; 13(1):37-41. PubMed ID: 1795560
[TBL] [Abstract][Full Text] [Related]
2. [Significance of determination of squamous cell carcinoma antigen in the follow up of patients with cancer of the uterine cervix].
Göcze P; Vahrson H
Orv Hetil; 1992 Dec; 133(50):3191-4. PubMed ID: 1461640
[TBL] [Abstract][Full Text] [Related]
3. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J
Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279
[TBL] [Abstract][Full Text] [Related]
4. [Clinical study of serum squamous cell carcinoma-related antigen levels in penile cancer].
Takahashi Y; Horie M; Isogai K; Takeuchi T; Shinoda I; Kuriyama M; Ban Y
Hinyokika Kiyo; 1987 Mar; 33(3):396-9. PubMed ID: 3618407
[TBL] [Abstract][Full Text] [Related]
5. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
6. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy.
Micke O; Bruns F; Schäfer U; Prott FJ; Willich N
Anticancer Res; 2005; 25(3A):1663-6. PubMed ID: 16033078
[TBL] [Abstract][Full Text] [Related]
7. Relationship between squamous cell carcinoma antigen levels and tumor volumes in patients with cervical carcinomas undergoing neoadjuvant chemotherapy.
Kim BG; Kim JH; Park SY; Lee JH; Lee ED; Lee KH; Park KB; Lee BH; Kim KH
Gynecol Oncol; 1996 Oct; 63(1):105-13. PubMed ID: 8898178
[TBL] [Abstract][Full Text] [Related]
8. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P
Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study on the measurement of squamous cell carcinoma (SCC)--related antigen in SCC].
Fukunaga M; Otsuka N; Sone T; Nagai K; Muranaka A; Furukawa T; Yanagi M; Yanagimoto S; Tomomitsu T; Morita R
Gan No Rinsho; 1985 Dec; 31(15):1885-8. PubMed ID: 3842935
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
Reesink-Peters N; van der Velden J; Ten Hoor KA; Boezen HM; de Vries EG; Schilthuis MS; Mourits MJ; Nijman HW; Aalders JG; Hollema H; Pras E; Duk JM; van der Zee AG
J Clin Oncol; 2005 Mar; 23(7):1455-62. PubMed ID: 15735121
[TBL] [Abstract][Full Text] [Related]
11. [Serum and pleural SCC-antigen levels in patients with pulmonary tuberculosis].
Suzuki K; Suzuki T; Akiyama J; Takashima Y; Yamada T; Kawashima M; Sato M; Sato H; Inui K; Wada H
Kekkaku; 1993 Sep; 68(9):551-7. PubMed ID: 8230956
[TBL] [Abstract][Full Text] [Related]
12. Monitoring the course of cervical carcinoma with the squamous cell carcinoma serum radioimmunoassay.
Holloway RW; To A; Moradi M; Boots L; Watson N; Shingleton HM
Obstet Gynecol; 1989 Dec; 74(6):944-9. PubMed ID: 2586961
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic value of SCC-TA4 determination in 4 localizations of epidermoid cancers. An experience of the FNCLCC subgroup of radio-analysis].
Daver A; Dalifard I; Pons-Anicet D; Krebs BP; Gosselin P; Cazin JL; Ricolleau G; Gaillard G; Gachon F; Goussard J
Bull Cancer; 1990; 77(8):781-92. PubMed ID: 2207367
[TBL] [Abstract][Full Text] [Related]
14. Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix.
Ohno T; Nakayama Y; Nakamoto S; Kato S; Imai R; Nonaka T; Ishikawa H; Harashima K; Suzuki Y
Cancer; 2003 Jun; 97(12):3114-20. PubMed ID: 12784349
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of serum squamous cell carcinoma antigen levels in invasive cervical cancer: is it cost-effective?
Chan YM; Ng TY; Ngan HY; Wong LC
Gynecol Oncol; 2002 Jan; 84(1):7-11. PubMed ID: 11748969
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary.
Suzuki M; Tamura N; Kobayashi H; Ohwada M; Terao T; Sato I
Gynecol Oncol; 2000 Jun; 77(3):405-9. PubMed ID: 10831350
[TBL] [Abstract][Full Text] [Related]
17. Comparison of pre-treatment CYFRA 21 - 1 and SCC-Antigen assay in primary cervical carcinoma - a preliminary report.
Puthucode-Easwaran S; Naik R; Athavale R; Handley G; Lopes A; Godfrey K; Hatem M
J Obstet Gynaecol; 2005 Jul; 25(5):486-8. PubMed ID: 16183586
[TBL] [Abstract][Full Text] [Related]
18. Study of a new tumor marker, CYFRA 21-1, in squamous cell carcinoma of the cervix, and comparison with squamous cell carcinoma antigen.
Tsai SC; Kao CH; Wang SJ
Neoplasma; 1996; 43(1):27-9. PubMed ID: 8843956
[TBL] [Abstract][Full Text] [Related]
19. Correlative light and immunohistological study of the HCG-like antigen in the squamous cell carcinoma of the human uterine cervix.
Yamasaki M; Ueda G; Inoue M; Tanaka Y; Tanizawa O; Kurachi K
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):151-4. PubMed ID: 7014735
[TBL] [Abstract][Full Text] [Related]
20. The impact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer.
Micke O; Prott FJ; Schäfer U; Tangerding S; Pötter R; Willich N
Anticancer Res; 2000; 20(6D):5113-5. PubMed ID: 11326679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
